logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8940742 B1

PDFFull Text
Date of Patent:
Jan. 27, 2015

Filed:

Mar. 15, 2013

Heterocyclic compounds and uses thereof

Applicants:

Infinity Pharmaceuticals, Inc., Cambridge, MA (US);

Intellikine Llc, La Jolla, CA (US);

Inventors:

Alfredo C. Castro, Winchester, MA (US);

Katrina Chan, Fremont, CA (US);

Catherine A. Evans, Somerville, MA (US);

Somarajannair Janardanannair, Woburn, MA (US);

Andre Lescarbeau, Somerville, MA (US);

Liansheng Li, San Diego, CA (US);

Tao Liu, Ashland, MA (US);

Yi Liu, San Diego, CA (US);

Pingda Ren, San Diego, CA (US);

Daniel A. Snyder, Somerville, MA (US);

Martin R. Tremblay, Melrose, MA (US);

Assignee:

Infinity Pharmaceuticals, Inc., Cambridge, MA (US);

Attorney:

Jones Day

Primary Examiner:

James O Wilson

Assistant Examiner:

Alexander R Pagano

Int. Cl.
CPC ...
A01N 43/58 (2006.01); A01N 43/60 (2006.01); A61K 31/50 (2006.01); A61K 31/495 (2006.01); C07D 401/12 (2006.01); C07D 487/04 (2006.01); C07D 405/12 (2006.01); C07D 491/056 (2006.01); C07D 401/14 (2006.01); C07D 217/24 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 495/04 (2006.01); C07D 403/12 (2006.01); C07D 217/26 (2006.01); C07D 401/04 (2006.01); C07D 417/14 (2006.01); C07D 491/048 (2006.01); C07D 513/04 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); C07D 487/04 (2013.01); C07D 405/12 (2013.01); C07D 491/056 (2013.01); C07D 401/14 (2013.01); C07D 217/24 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 495/04 (2013.01); C07D 403/12 (2013.01); C07D 217/26 (2013.01); C07D 401/04 (2013.01); C07D 417/14 (2013.01); C07D 491/048 (2013.01); C07D 513/04 (2013.01); C07D 519/00 (2013.01);
Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Find Patent Forward Citations

Loading…